(Q40692331)

22 September 2017

A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth (English)

1 reference

22 September 2017

1 reference

1 reference

4

Harald Wodrich

1 reference

22 September 2017

7

Brian P. Eliceiri

1 reference

22 September 2017

3

Jürgen C. Becker

1 reference

22 September 2017

Rong Xiang

2

1 reference

22 September 2017

Ursula Pertl

5

1 reference

22 September 2017

Gabriele Karsten

6

1 reference

22 September 2017

Andreas G. Niethammer

1

1 reference

22 September 2017

Ralph A. Reisfeld

8

1 reference

22 September 2017

language of work or name

English

0 references

publication date

4 November 2002

1 reference

22 September 2017

1 reference

22 September 2017

8

1 reference

22 September 2017

1369-1375

1 reference

22 September 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1202-794

22 September 2017

0 references

cites work

Addressing tumor blood vessels

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Antiangiogenic gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Angiostatin induces and sustains dormancy of human primary tumors in mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Antiangiogenic tumour therapy: will it work?

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Tumor angiogenesis and tissue factor

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Can mosaic tumor vessels facilitate molecular diagnosis of cancer?

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

VEGF regulates cell behavior during vasculogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

VEGF: an update on biological and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Blood vessel formation: what is its molecular basis?

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

VEGF receptor signaling in tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Antiangiogenic and antivascular therapy for cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Genes expressed in human tumor endothelium

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Oral somatic transgene vaccination using attenuated S. typhimurium.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

The healing skin wound: a novel site of action of the chemokine C10.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Large induction of keratinocyte growth factor expression in the dermis during wound healing

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Atm-deficient mice: a paradigm of ataxia telangiectasia

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-794

7 January 2021

Identifiers

DOI

10.1038/NM1202-794

1 reference

22 September 2017

0 references

1 reference